New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Psyence Biomedical Ltd.

PBM

Healthcare Biotechnology

2.97 0.11 +3.85%

After hours trading: 3.01, up 1.35%, last trade Fri 4:09pm Eastern.

Market cap
$10.9M
P/E
0.1×
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
—
Net debt / EBITDA
1.2×
Payout ratio
—

What it owns vs. what it owes Q3 FY2025, Sep 30, 2025

Shareholders’ equity is 92.6% of the balance sheet. What is a balance sheet?

Sep 30, 2025 · total $12.8M

Owns

$8.7KLong-term assets
$432.3KOther short-term assets
$12.4MCash & all investments

Funded by

$11.9MShareholders’ equity
$943.1KOther liabilities

Debt is 0.00% of the total; shareholders’ equity 92.6%.

Sep '25 Mar '25 Sep '24 Mar '24 Older periods
Total current assets
7.63 6.56 2.24 1.13
Total non-current assets
5.18 0.76 0.01 0.01
Total Assets
12.81 7.32 2.25 —
Total current liabilities
0.94 0.59 3.51 12.10
Total liabilities
0.94 0.59 3.51 12.10
Common Equity (Total)
11.87 6.72 (1.26) (10.97)
Shareholders Equity (Total)
11.87 6.72 (1.26) (10.97)
Other line items

Show all line items

In millions of $ except per-share values · columns are period end dates